Cargando…
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
Background. End-stage liver disease (ESLD) is an important cause of morbidity among human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients. Quantifying the risk of this outcome over time could help determine which coinfected patients should be targeted for risk factor modific...
Autores principales: | Lo Re, Vincent, Kallan, Michael J., Tate, Janet P., Lim, Joseph K., Goetz, Matthew Bidwell, Klein, Marina B., Rimland, David, Rodriguez-Barradas, Maria C., Butt, Adeel A., Gibert, Cynthia L., Brown, Sheldon T., Park, Lesley S., Dubrow, Robert, Reddy, K. Rajender, Kostman, Jay R., Justice, Amy C., Localio, A. Russell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536329/ https://www.ncbi.nlm.nih.gov/pubmed/26284259 http://dx.doi.org/10.1093/ofid/ofv109 |
Ejemplares similares
-
Risks of Opportunistic Infections in People With Human Immunodeficiency Virus With Cancers Treated With Chemotherapy
por: Makinson, Alain, et al.
Publicado: (2021) -
The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014) -
Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics
por: Berenguer, Juan, et al.
Publicado: (2016) -
Highly Successful Hepatitis C Virus (HCV) Treatment Outcomes in Human Immunodeficiency Virus/HCV-Coinfected Patients at a Large, Urban, Ryan White Clinic
por: Patel, Manish, et al.
Publicado: (2017) -
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
por: Marathe, Gayatri, et al.
Publicado: (2022)